Patient-centred advice is effective in improving adherence to medicines

Springer Science and Business Media LLC - Tập 28 - Trang 165-170 - 2006
Sarah Clifford1, Nick Barber2, Rachel Elliott3, Elaine Hartley4, Rob Horne5
1The School of Pharmacy, London, UK
2Department of Practice and Policy, The School of Pharmacy, London, UK
3School of Pharmacy and Pharmaceutical Sciences, University of Manchester, Manchester, UK
4Alliance Pharmacy, Faltham, UK
5School of Pharmacy and Biomolecular Sciences, University of Brighton, Brighton, UK

Tóm tắt

To assess the effects of pharmacists giving advice to meet patients’ needs after starting a new medicine for a chronic condition. A prospective health technology assessment including a randomised controlled trial of a pharmacist-delivered intervention to improve adherence using a centralised telephone service to patients at home in England. Patients were eligible for recruitment if they were receiving the first prescription for a newly prescribed medication for a chronic condition and were 75 or older or suffering from stroke, cardiovascular disease, asthma, diabetes or rheumatoid arthritis. Incidence of non-adherence, problems with the new medicine, beliefs about the new medicine, safety and usefulness of the interventions. Five hundred patients consented and were randomised. At 4-week follow-up, non-adherence was significantly lower in the intervention group compared to control (9% vs. 16%, P = 0.032). The number of patients reporting medicine-related problems was significantly lower in the intervention group compared to the control (23% vs. 34%, P = 0.021). Intervention group patients also had more positive beliefs about their new medicine, as shown by their higher score on the “necessity-concerns differential” (5.0 vs. 3.5, P = 0.007). The phone calls took a median of 12 min each. Most advice was judged by experts to be safe and helpful, and patients found it useful. Overall, these findings show benefits from pharmacists meeting patients’ needs for information and advice on medicines, soon after starting treatment. While a substantially larger trial would be needed to confirm that the effect is real and sustained, these initial findings suggest the service may be safe and useful to patients.

Tài liệu tham khảo

Smith M. The cost of non-compliance and the capacity of improved compliance to reduce health care expenditures. In: Improving medication compliance. Proceedings of a Symposium held in Washington DC, November 1984. Reston, Virginia: National Pharmaceutical Council, 1985;35-4. Horne R. Adherence to medication: a review of the existing literature. In: Myers L, Midence K, editors. Adherence to treatment in medical conditions. Amsterdam: Harwood Academic Press; 1998. p 285–310. ISBN: 9057022656. Lewis A. Noncompliance: A $100 billion problem. Remington Report. 1997;5(4):14-. McDonald HP, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication prescriptions: scientific review. JAMA 2002;288:2868-9. Leventhal H, Cameron LD. Behavioral theories and the problem of compliance. Patient Educ Couns 1987;10:117-8. Horne R, Weinman J. Patients’ beliefs about medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res 1999;47(6):555-7. Horne R. Treatment perceptions and self-regulation. In: Cameron LD, Leventhal H, editors. The self-regulation of health and illness behaviour. London: Routledge Taylor & Francis Group, 2003. p 138–53. ISBN: 0415297001. Barber N, Parsons J, Clifford S, Darracott R, Horne R. Patients’ problems with new medication for chronic conditions. Qual Saf Health Care 2004;13(3):172–5. Ware JE, Sherbourne CD. The MOS 36 item short form health survey (SF-36): Conceptual framework and item selection. Med Care 1992;30:473. Horne R, Weinman J, Hankins M. The beliefs about medicines questionnaire: the development of a new method for assessing the cognitive representation of medication. Psychol Health 1999;14:1–24. Haynes RB, McDonald HP, Garg AX. Helping patients follow prescribed treatment: clinical applications. JAMA 2002;288:2880-. Haynes RB, Taylor DW, Sackett DL, Gibson ES, Bernholtz CD, Mukherjee J. Can simple clinical measures detect patient non-compliance? Hypertension 1980;2:757-4. Barber N. Should we consider non-compliance a medical error? Qual Saf Health Care 2002;11:81-. Dean B, Barber N. Validity and reliability of observational methods for studying medication administration errors. Am J Health-Syst Pharm 2001;58:54-. Horne R, Weinman J. Patients’ beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res 1999;47:555-7. Department of Health. Pharmacy in the future. 2000. Available at: http://www.dh.gov.uk/assetRoot/04/06/82/04/04068204.pdf. (Accessed March 13th 2005). Department of Health. A Vision for Pharmacy in the New NHS. 2003. [26 pages]. Available at: http://www.dh.gov.uk/assetRoot/04/06/83/56/04068356.pdf. (Accessed March 13th 2005). Blenkinsopp A, Phelan M, Bourne J, Dakhil N. Extended adherence support by community pharmacists for patients with hypertension: a randomised controlled trial. Int J Pharm Pract 2000;8:165-5. Goodyer LI, Miskelly F, Milligan P. Does encouraging good compliance improve patients’ clinical condition in heart failure? Br J Clin Pharmacol 1995;49(4):173–6. Kaplan RM, Simon HJ. Compliance in medical care: reconsideration of self-predictions. Ann Behav Med 1990;12:66–71. Emanuel EJ, Emanuel LL. Four models of the physician-patient relationship. JAMA 1992;267:2221-6.